Endologix Inc. IntuiTrak Delivery System Receives Shonin Approval for Marketing in Japan  
1/2/2013 9:08:37 AM

IRVINE, Calif., Dec. 31, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that its distribution partner in Japan, Cosmotec Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the IntuiTrak® Delivery System. The IntuiTrak System delivers the Company's Powerlink® anatomical fixation stent graft for the minimally invasive endovascular repair of abdominal aortic aneurysms (AAA).